Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Merck
Johnson and Johnson
Harvard Business School
Express Scripts

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Iodophenyl

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Iodophenyl: Sponsors, patents, clinical trial progress

Iodophenyl is an investigational drug.

There have been 9 clinical trials for Iodophenyl. The most recent clinical trial was a Phase 2 trial, which was initiated on July 12th 2017.

The most common disease conditions in clinical trials are Parkinson Disease, Colorectal Neoplasms, and Glioma. The leading clinical trial sponsors are Cellectar Biosciences, Inc., Anders Fink-Jensen, MD, DMSci, and Molecular Insight Pharmaceuticals, Inc.

Recent Clinical Trials for Iodophenyl
TitleSponsorPhase
Trametinib and TAS-102 in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by SurgeryCity of Hope Medical CenterPhase 1
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Neurobiology Research Unit, Rigshospitalet, CopenhagenPhase 2
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?Section of Biostatistics University of Copenhagen, CopenhagenPhase 2

See all Iodophenyl clinical trials

Clinical Trial Summary for Iodophenyl

Top disease conditions for Iodophenyl
Top clinical trial sponsors for Iodophenyl

See all Iodophenyl clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
McKinsey
McKesson
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.